Yonsei Med J.  2005 Apr;46(2):198-205. 10.3349/ymj.2005.46.2.198.

The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria

• Choi SH
• Ahn CW
• Cha BS
• Chung YS
• Lee KW
• Lee HC
• Huh KB
• Kim DJ

• KMID: 1734044
• DOI: http://doi.org/10.3349/ymj.2005.46.2.198

Abstract

The aims of this study were to compare the prevalence of the metabolic syndrome according to the WHO and NCEP ATP III criteria in Korean adults, and to compare the prevalence of the metabolic syndrome with the results in previous Korean studies. The study comprised 1, 230 subjects (627 men, 603 women) aged 30-79 years (mean 52.4+/-10.3 years) who underwent medical check-up from April to June, 2001 in the Korea Association of Health (KAH). The prevalence of the metabolic syndrome according to the modified WHO criteria was 21.8% of men and 19.4% of women. However, the prevalence was increased 1.6 times (34.2%) in men and 2.0 times (38.7%) in women using the modified NCEP criteria. The prevalence of the metabolic syndrome has varied widely according to differences in the criteria. Thus, further studies are necessary to define the appropriate criteria of the metabolic syndrome for Korean adults.

Keyword

Metabolic syndrome; criteria; obesity; prevalence

MeSH Terms

Adult
Aged
Asian Continental Ancestry Group/*statistics & numerical data
*Cholesterol
Comparative Study
Female
*Health Education
Humans
Korea/epidemiology
Male
Metabolic Syndrome X/*diagnosis/*epidemiology
Middle Aged
Practice Guidelines
Prevalence
*World Health Organization

Figure

• 

  Fig. 1 Discrepancy of the metabolic syndrome between the modified WHO and NCEP criteria.

Reference

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988. 37:1595–1607.

2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998. 15:539–553.

3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001. 285:2486–2496.

4. Deurenberg-Yap M, Chew SK, Deureberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev. 2002. 3:209–215.

5. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev. 2002. 3:141–146.

6. Gurrici S, Hartriyanti Y, Hautvast JG, Deurenberg P. Relationship between body fat and body mass index: differences between Indonesians and Dutch Caucasians. Eur J Clin Nutr. 1998. 52:779–783.

7. Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower boy mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994. 60:23–28.

8. The Asia-Pacific perspective: redefining obesity and its treatment. Western Pacific Regional Office of the World Health Organization, The International Obesity Task Force. 2000. Sydney: Health Communications Australia;http://www.obesityasiapacific.com.

9. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Schmidt MI, et al. Familial components of the multiple metabolic syndrome: the ARIC Study. Diabetologia. 1997. 40:963–970.

10. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999. 245:163–174.

11. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001. 24:683–689.

12. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: An urban-rural comparison. Diabetes Care. 2001. 24:275–279.

13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination survey. JAMA. 2002. 287:356–359.

14. Jee SH, Appel LJ, Suh I, Whelton PK, Kim IS. Prevalence of cardiovascular risk factors in South Korean adults: Results from the Korea Medical Insurance Corporation (KMIC) Study. Ann Epidemiol. 1998. 8:14–21.

15. Kim SW, Kim JY, Kim ES, Kim YI, Lee MS, Kim HH, et al. Prevalence of insulin resistance syndrome in subjects living in Jungup district, Korea. J Korean Diabet Assoc. 1999. 23:70–78.

16. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP-ATP III among the urban Korean population. Korean J Med. 2002. 63:290–298.

17. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci. 2004. 19:195–201.

18. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol. 2004. 33:328–336.

19. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997. 20:1087–1092.

20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifugation. Clin Chem. 1972. 18:499–502.

21. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol. 1999. 19:1992–1997.

22. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med. 1997. 157:1413–1418.

23. Kim YI, Kim C-H, Choi CS, Chung YE, Lee MS, Lee SI, et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract. 2001. 52:145–152.